Advertisement
Advertisement

Top 25 Most-Viewed Articles on The Body PRO

The Future of 2-Drug Regimens for People With HIV
Do People With HIV Need Annual Physical Examinations?
Expert: Long-Awaited CDC HIV Report on Conception Options for Serodiscordant Couples Is Disappointing and Confusing
Canadian Study Finds Increased Risk of Death Among HIV-Positive Indigenous People
This Week in HIV Research: Early Treatment With Broadly Neutralizing Antibodies Suppresses SHIV in Monkeys
Liquor Tied to Gut Integrity and Inflammation in Adults With HIV
High Rates of Undocumented Efavirenz-Related Side Effects in Uganda
Unexpected Side Effects With Generic Abacavir -- and Potential for Rare Reactions to Other Generic ARVs
Depression Score Falls by Half With 12 Months of Antiretroviral Therapy
Case Report of Capsulitis With Elvitegravir and Cobicistat (EVG/c)
Inflammation Associated With Pre-Treatment Viral Load in People With HIV
This Week in HIV Research: Long-Term Nonprogressors Have Greater Thymic Function; and HCV Reinfection Rates Examined
Increased Risk of ART Failure After Low-Level Viraemia in a Large South African Cohort
Impact of HIV, Age and Comorbidity on Depression and Quality of Life
Current HIV Prevention Methods
Depression Not Tied to Mortality Risk in Current HIV Treatment Era
This Week in HIV Research: New Discovery in How HIV Hijacks a Cell
Dolutegravir Pharmacokinetics in Pregnancy
Beyond the Gender Binary: HIV Support for Those Who Check Neither M Nor F
Should You Answer Medical Questions From Clinicians You Don't Know About Patients You've Never Seen?
This Week in HIV Research: Maintenance Therapy Regimen Containing Lamivudine May Be Viable Option
Fat Gains Continue and Lean Mass Falls in Group on Long-Term HIV Therapy
TelePrEP: Sidestepping Stigma in Rural America
Condomless Sex, Younger Age Tied to Rising Syphilis Rate in Swiss HIV Group
Talking About Fatherhood and Reproductive Health With Heterosexual Men Living With HIV




This article was provided by TheBodyPRO.com.
 

Advertisement

The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.